CSS LLC’s Avadel Pharmaceuticals AVDL Stock Holding History

CSS LLC’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,900	Closed	-$84K	–	990
2025 Q4	$84K	Buy	+3,900	New	+$75.7K	﹤0.01%	865

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

CSS LLC's AVDL Position: Q1 2026 in Review

CSS LLC sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 59,037 shares — an estimated $1.27M sold.

CSS LLC first reported a position in AVDL in Q4 2025 and held it in 1 quarter. The position peaked at $1.27M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

CSS LLC reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
CSS LLC sold 59,037 Avadel Pharmaceuticals shares in Q1 2026, an estimated $1.27M.
CSS LLC first reported a position in Avadel Pharmaceuticals in Q4 2025 and held it in 1 quarter.
CSS LLC's Avadel Pharmaceuticals position peaked at $1.27M in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on CSS LLC's 13F filing for Q1 2026, filed 15 May 2026.